首页> 外文OA文献 >Serum Metabolite Biomarkers Predictive of Response to PD-1 Blockade Therapy in Non-Small Cell Lung Cancer

【2h】

Serum Metabolite Biomarkers Predictive of Response to PD-1 Blockade Therapy in Non-Small Cell Lung Cancer

机译：血清代谢物生物标志物预测非小细胞肺癌PD-1阻断治疗的反应

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Xiaoqun Nie; Liliang Xia; Fang Gao; Lixia Liu; Yi Yang; Yingying Chen; Huangqi Duan; Yaxian Yao; Zhiwei Chen; Shun Lu; Ying Wang; Chen Yang;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Serum Metabolite Biomarkers Predictive of Response to PD-1 Blockade Therapy in Non-Small Cell Lung Cancer [J] . Xiaoqun Nie, Liliang Xia, Fang Gao, Frontiers in Molecular Biosciences . 2021,第a期

机译：血清代谢物生物标志物预测非小细胞肺癌PD-1阻断治疗的反应
2. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy [J] . Wu Si-Pei, Liao Ri-Qiang, Tu Hai-Yan, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2018,第4期

机译：基质PD-L1阳性调节性T细胞和PD-1阳性CD8阳性T细胞定义了非小细胞肺癌不同亚群的响应至PD-1 / PD-L1阻断免疫疗法
3. Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non-small cell lung cancer [J] . Shien Kazuhiko, Papadimitrakopoulou Vassiliki A., Wistuba Ignacio I. Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2016,第Null期

机译：非小细胞肺癌对PD-1 / PD-L1免疫检查点抑制剂反应的预测生物标志物
4. Radiomics Biomarkers from PET/CT Multi-modality Fusion Images for the Prediction of Immunotherapy Response in Advanced Non-small Cell Lung Cancer Patients [C] . Wei Mu, Jin Qi, Hong Lu, SPIE Medical Imaging Conference . 2018

机译：PET / CT多模态融合图像的放射性标记生物标志物用于预测晚期非小细胞肺癌患者的免疫治疗反应
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. Serum Metabolite Biomarkers Predictive of Response to PD-1 Blockade Therapy in Non-Small Cell Lung Cancer [O] . Xiaoqun Nie, Liliang Xia, Fang Gao, 2021

机译：血清代谢物生物标志物预测非小细胞肺癌PD-1阻断治疗的反应
7. P1.04-72 Tumor Mutational Burden as a Potential Predictive Biomarker of Response to PD-1/PD-L1 Blockade in Non-Small Cell Lung Cancer [O] . H. Kim, H.J.K. Kwon, E.S.K. Kim, 2019

机译：P1.04-72肿瘤突变负担作为对非小细胞肺癌PD-1 / PD-L1阻断的潜在预测生物标志物

Serum Metabolite Biomarkers Predictive of Response to PD-1 Blockade Therapy in Non-Small Cell Lung Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅